America reaches major vaccination milestone with HALF of all adults who have now received at least one stroke, CDC shows
- Half of American adults have received at least one photo of COVID-19 vaccine, says CDC
- About 130 million Americans 18 years of age or older have received at least one dose
- About two-thirds of them – 84 million – were completely vaccinated, says the CDC
- Officials will resume Johnson & Johnson vaccine this week
- CDC orders a single-dose break after rare cases of blood clots
Half of all U.S. adults have received at least one COVID-19 shot, the government announced Sunday, marking another milestone in the nation’s largest vaccination campaign, but leaving more work to convince skeptical Americans to and roll up your sleeves.
Nearly 130 million people aged 18 or older received at least one dose of the vaccine, or 50.4 percent of the total adult population, the Centers for Disease Control and Prevention reported.
Nearly 84 million adults, or about 32.5% of the population, have been completely vaccinated.
The US eliminated the 50% margin for adults just one day after the total number of coronavirus deaths exceeded 3 million, according to totals compiled by Johns Hopkins University, although the actual number is considered to be significantly higher.
A registered nurse administers a dose of Moderna Covid-19 vaccine on Saturday at a pop-up vaccination site of the Veterans Administration (VA) Long Beach Healthcare System in Gardena, California, on Saturday
In other developments, the nation’s leading infectious disease expert said on Sunday that the government is likely to resume use of COVID-19 Johnson & Johnson this week, possibly with wider restrictions or warnings following reports of very rare clots. of blood.
Dr. Anthony Fauci, in a series of news broadcast interviews, said he is awaiting a decision when advisers from the Centers for Disease Control and Prevention meet Friday to discuss the breakdown in the J&J single-dose vaccine.
“I would be very surprised if we don’t resume in some form by Friday,” he said.
“I don’t really anticipate that they want to stretch it a little more.”
As of Sunday, nearly 40% of the US population has received at least one dose. More than 50 percent of adults received at least one stroke, according to the CDC
Nearly 84 million adults, or about 32.5% of the population, have been completely vaccinated
Fauci, who is President Joe Biden’s chief medical adviser, said he believes federal regulators could bring the fires back with age or gender restrictions or a general warning to be administered in a way “a little different from us” were before the break.
The J&J vaccine was in the tongue after the CDC and the Food and Drug Administration said last week that they needed more evidence to decide whether a handful of unusual blood clots were linked to the shooting – and if so, how big it is. the risk.
Reports are rare – six out of more than 7 million US J&J vaccinations.
The clots were found in six women between the ages of 18 and 48. One person died.
The interim FDA commissioner said the break was expected to last only a few days.
However, last Tuesday’s decision triggered swift action in Europe and elsewhere.
Fauci said he seriously doubts that the US will permanently stop using the J&J vaccine.
“I don’t think that’s going to happen,” he said.
“The break was to take a look, to make sure we know all the information we can have in this time frame, and also to warn some doctors out there who might see people, especially women, who they have this special adverse event, which they treat accordingly. ‘
“I think he’ll probably say, ‘OK, we’ll use it. But be careful in these circumstances. “
More than 6.8 million doses of J&J vaccine have been administered in the United States, the vast majority without side effects or mild side effects.
Authorities said they had found no signs of clot problems with the most widely used COVID-19 vaccines in the United States – from Moderna and Pfizer.
Fauci appeared on Meet the Press on NBC, CNN State of the Union, ABC This Week and CBS Face the Nation.